The Daily Pulse

Health

FDA forms new safety council for vaccines and gene therapies

Reported by Faizan Khan (Staff Writer) · The Hindu - Health ·

Source: The Hindu
Worth knowing
HealthFDA forms new safety council for vaccines and gene therapies
Representative image · Pexels

The United States Food and Drug Administration has set up a new internal safety body inside its biologics center to oversee approved products like vaccines, gene therapies, and blood products after they reach the market.

Structure and Role

Named the CBER Safety Council, this group will report directly to the director of the Center for Biologics Evaluation and Research. This setup separates safety reviews after approval from the offices that initially approve the products. The new body replaces an older safety working group and brings together senior scientific and regulatory officials to check safety signals, study risks and benefits, and suggest regulatory steps. Its job covers emerging safety issues, possible label updates, risk plans, safety studies after market entry, and advice on taking products off the market if needed.

Background and Context

Context

This move comes as biologic products and cell and gene therapies grow more complex and get used by much larger patient groups. The council will work with outside groups like the Centers for Disease Control and Prevention and the National Institutes of Health. It will use tracking systems such as the Vaccine Adverse Event Reporting System and the FDA Sentinel program. The council officially started on November 19, and the agency plans to share more details about who is in it and how it is built later.

Read more at The Hindu - Health →